Clinical Trial

Model-Informed Precision Dosing of Tacrolimus in Pediatric Kidney Transplantation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to develop a novel and applicable dosing algorithm that helps support the clinical decision to achieve tacrolimus levels within the optimal immunosuppression range despite sparse sampling in routine clinical practice in pediatric kidney transplantation. This clinical decision support tool (CDST) is based on a hybrid population pharmacokinetics-machine learning approach aiming for tacrolimus dose individualization and reducing the risk of acute graft rejection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-18.
Trial Details
NCT Number NCT07549230
Lead Sponsor Helwan University
Collaborators: Cairo University
Conditions Pediatric Kidney Transplantation
Enrollment 130 participants
Start Date 2026-06-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-29